# A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome

> **NCT00675896** · PHASE4 · COMPLETED · sponsor: **Dr Alexander McIntyre Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Quetiapine Fumarate Sustained Release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00675896
- **Lead sponsor:** Dr Alexander McIntyre Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675896, "A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00675896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*